Expanding Veterans’ Access to Emerging Treatments Act
Congress Proposes Bill to Give Veterans Access to Psychedelic and Experimental Medical Treatments
Legislative Progress
Key Points
- Congress is considering a plan to help veterans who struggle with mental health and physical pain by testing new types of medicine. The bill would create a special program at the Department of Veterans Affairs to study treatments that aren't widely available yet, like certain psychedelic drugs and advanced medical devices.
- The program would focus on veterans dealing with serious conditions like PTSD, depression, anxiety, and traumatic brain injuries. It also aims to help those with chronic pain or drug and alcohol addictions who haven't found relief through traditional doctors or standard medications.
- Under this plan, veterans could join clinical trials to try treatments like psilocybin, MDMA, and ketamine. It also includes high-tech options like deep brain stimulation and oxygen therapy. There is also a "compassionate access" rule so veterans can try these therapies if their situation is urgent.
- The Department of Veterans Affairs would have to pick a leader for this program within 60 days and start the research within 90 days. After one year, they must report back to Congress on how well the treatments are working, how much they cost, and if they are safe for wider use.
- The program is designed to last for at least two years. After that time, the Secretary of Veterans Affairs will review the results and decide whether to keep the program going or shut it down based on how helpful it has been for veterans.
Impact Analysis
Personal Impact
How this policy affects specific groups of people
Milestones
Referred to the House Committee on Veterans' Affairs.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
4 articles
Bipartisan Congressional Lawmakers File Bill Directing VA To Study Psychedelics As Alternative Therapies For Veterans
Reps. Jack Bergman and Lou Correa filed the 'Expanding Veterans’ Access to Emerging Treatments Act' to direct the VA to carry out clinical trials on innovative treatments, including psychedelics like psilocybin and MDMA, and develop compassionate access protocols for veterans with PTSD.
Clearmind's MEAI added to U.S. veterans therapy bill
The Expanding Veterans' Access to Emerging Treatments Act of 2026 (H.R. 7091) directs the VA to establish an investigational research and extended access program for innovative therapies including psilocybin, MDMA, and MEAI to address unmet medical needs in veterans.

Veterans’ 2026 Priorities Put Health Care, Suicide Prevention to Congress
As Congress returns for 2026, veterans' advocates are pressing lawmakers to prioritize access to quality healthcare and suicide prevention. The agenda includes scaling innovative care and evidence-based therapies beyond VA facilities to reach veterans in crisis.
Source Information
Document Type
Congressional Bill
Official Title
Expanding Veterans’ Access to Emerging Treatments Act
Data Sources
Sponsor
Cosponsors
(2)Analysis generated by AI. Always verify with official sources.